SCOPUS 정보 검색 플랫폼

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 2, 2002, Pages 392-397

Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers

(5) Hsyu, Poe Hirr a Pithavala, Yazdi K a Gersten, Merril a Penning, Carol A a Kerr, Bradley M a

a AGOURON PHARMACEUTICALS INC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AG 7185; ANTIRHINOVIRAL AGENT; ANTIVIRUS AGENT; DRUG METABOLITE; PLACEBO; PROTEINASE INHIBITOR; RUPINTRIVIR; UNCLASSIFIED DRUG;

ADULT; ANOSMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEHYDRATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG SAFETY; DRUG SELECTIVITY; DRUG TOLERABILITY; DYSGEUSIA; EPISTAXIS; HEADACHE; HUMAN; HUMAN RHINOVIRUS; MALE; NAUSEA; NORMAL HUMAN; NOSE MUCUS; PHARYNGITIS; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RHINITIS; VERTIGO;

ADULT; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; OXAZOLES; PYRROLIDINES; RHINOVIRUS;

EID: 0036146744 PISSN: 00664804 EISSN: None Source Type: Journal
DOI: 10.1128/AAC.46.2.392-397.2002 Document Type: Article

Times cited : (44)

References (8)

1
- 1842292104
- Frequency and natural history of rhinovirus infections in adults during autumn
- (1997) J. Clin. Microbiol. , vol.35 , pp. 2864-2868
- Arruda, E.¹ Pitkaranta, A.² Witek Jr., T.J.³ Doyle, C.A.⁴ Hayden, F.G.⁵

2
- 0033535596
- Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitor. 4. Incorporation of P1 lactam moieties as L-glutamine replacements
- (1999) J. Med. Chem. , vol.42 , pp. 1213-1224
- Dragovich, P.S.¹ Prins, T.J.² Zhou, R.³ Webber, S.E.⁴ Marakovits, J.T.⁵ Fuhrman, S.A.⁶ Patick, A.K.⁷ Matthews, D.A.⁸ Lee, C.A.⁹ Ford, C.E.¹⁰ Burke, B.J.¹¹ Rejto, P.A.¹² Hendrickson, T.F.¹³ Tuntland, T.¹⁴ Brown, E.L.¹⁵ Meador III, J.W.¹⁶ Ferre, R.A.¹⁷ Harr, J.E.V.¹⁸ Kosa, M.B.¹⁹ Worland, S.T.²⁰ more..

3
- 0002331617
- Rhinovirus
- D. D. Richman, R. J. Whitley, and F. G. Hayden (ed.). Churchill Livingstone, New York, N.Y.
- (1997) Clinical virology , pp. 1025-1047
- Gwaltney Jr., J.M.¹ Rueckert, R.R.²

4
- 13044300859
- Structure-assisted design of mechanism based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes
- (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 11000-11007
- Matthews, D.A.¹ Dragovich, P.S.² Webber, S.E.³ Fuhrman, S.A.⁴ Patick, A.K.⁵ Zalman, L.S.⁶ Hendrickson, T.⁷ Prins, T.J.⁸ Marakovits, J.T.⁹ Zhou, R.¹⁰ Tikhe, J.¹¹ Ford, C.E.¹² Meador III, J.W.¹³ Ferre, R.A.¹⁴ Brown, E.L.¹⁵ Binford, S.L.¹⁶ Delisle, D.M.¹⁷ Worland, S.T.¹⁸

5
- 0028235532
- Structure of human rhinovirus 3C protease reveals a trypsinlike polypeptide fold. RNA-binding site, and means for cleaving precursor polyprotein
- (1994) Cell , vol.77 , pp. 761-771
- Matthews, D.A.¹ Smith, W.W.² Ferre, R.A.³ Condon, B.⁴ Budahazi, G.⁵ Sisson, W.⁶ Villafranca, J.E.⁷ Janson, C.A.⁸ McElrov, H.E.⁹ Gribskov, C.L.¹⁰ Worland, S.¹¹

6
- 0032870120
- In vitro antiviral activity of ruprintrivir, a potent inhibitor of human rhinovirus 3C protease
- (1999) Antimicrob. Agents Chemother. , vol.43 , pp. 2444-2450
- Patick, A.K.¹ Binford, S.L.² Brothers, M.A.³ Jackson, R.L.⁴ Ford, C.E.⁵ Diem, M.D.⁶ Maldonado, F.⁷ Dragovich, P.S.⁸ Zhou, R.⁹ Prins, T.J.¹⁰ Fuhrman, S.A.¹¹ Meador, J.W.¹² Zalman, L.S.¹³ Matthews, D.A.¹⁴ Worland, S.T.¹⁵

7
- 0031958765
- What's new with common colds? Complications and management
- (1998) Infect. Med. , vol.15 , pp. 117-128
- Pitkaranta, A.¹ Hayden, F.G.²

8
- 0034050610
- (2000) Inhibition of human rhinovirus-induced cytokine production by AG&088, a human rhinovirus 3C protease inhibitor , vol.44 , pp. 1236-1241
- Zalman, L.S.¹ Brothers, M.A.² Dragovich, P.S.³ Zhou, R.⁴ Prins, T.J.⁵ Worland, S.T.⁶ Patick, A.K.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.